Your browser doesn't support javascript.
A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants.
Jassat, Waasila; Mudara, Caroline; Vika, Caroline; Welch, Richard; Arendse, Tracy; Dryden, Murray; Blumberg, Lucille; Mayet, Natalie; Tempia, Stefano; Parker, Arifa; Nel, Jeremy; Perumal, Rubeshan; Groome, Michelle J; Conradie, Francesca; Ndjeka, Norbert; Sigfrid, Louise; Merson, Laura; Cohen, Cheryl.
  • Jassat W; National Institute for Communicable Disease, Division of the National Health Laboratory Services, Johannesburg, South Africa; Right to Care, Centurion, South Africa. Electronic address: waasilaj@nicd.ac.za.
  • Mudara C; National Institute for Communicable Disease, Division of the National Health Laboratory Services, Johannesburg, South Africa.
  • Vika C; National Institute for Communicable Disease, Division of the National Health Laboratory Services, Johannesburg, South Africa.
  • Welch R; National Institute for Communicable Disease, Division of the National Health Laboratory Services, Johannesburg, South Africa; Right to Care, Centurion, South Africa.
  • Arendse T; National Institute for Communicable Disease, Division of the National Health Laboratory Services, Johannesburg, South Africa; Right to Care, Centurion, South Africa.
  • Dryden M; National Institute for Communicable Disease, Division of the National Health Laboratory Services, Johannesburg, South Africa.
  • Blumberg L; National Institute for Communicable Disease, Division of the National Health Laboratory Services, Johannesburg, South Africa; Right to Care, Centurion, South Africa.
  • Mayet N; National Institute for Communicable Disease, Division of the National Health Laboratory Services, Johannesburg, South Africa.
  • Tempia S; National Institute for Communicable Disease, Division of the National Health Laboratory Services, Johannesburg, South Africa; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Parker A; Divisions of General Medicine and Infectious Diseases, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.
  • Nel J; Division of Infectious Diseases, Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa.
  • Perumal R; Division of Pulmonology and Critical Care, Department of Medicine, University of KwaZulu-Natal, Berea, Durban, South Africa; South African Medical Research Council-CAPRISA HIV/TB Pathogenesis and Treatment Research Unit, Centre for the AIDS Programme of Research in South Africa, University of KwaZul
  • Groome MJ; National Institute for Communicable Disease, Division of the National Health Laboratory Services, Johannesburg, South Africa; School of Pathology, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.
  • Conradie F; Clinical HIV Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.
  • Ndjeka N; Drug-Resistant TB, TB & HIV Directorate, National Department of Health, Pretoria, South Africa and University of KwaZulu-Natal, Durban, South Africa.
  • Sigfrid L; International Severe Acute Respiratory and emerging Infections Consortium (ISARIC), Pandemic Sciences Institute, University of Oxford, Oxford, United Kingdom.
  • Merson L; International Severe Acute Respiratory and emerging Infections Consortium (ISARIC), Pandemic Sciences Institute, University of Oxford, Oxford, United Kingdom.
  • Cohen C; National Institute for Communicable Disease, Division of the National Health Laboratory Services, Johannesburg, South Africa; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Int J Infect Dis ; 128: 102-111, 2023 Mar.
Article in English | MEDLINE | ID: covidwho-2241792
ABSTRACT

OBJECTIVES:

The study aimed to describe the prevalence of and risk factors for post-COVID-19 condition (PCC).

METHODS:

This was a prospective, longitudinal observational cohort study. Hospitalized and nonhospitalized adults were randomly selected to undergo telephone assessment at 1, 3, and 6 months. Participants were assessed using a standardized questionnaire for the evaluation of symptoms and health-related quality of life. We used negative binomial regression models to determine factors associated with the presence of ≥1 symptoms at 6 months.

RESULTS:

A total of 46.7% of hospitalized and 18.5% of nonhospitalized participants experienced ≥1 symptoms at 6 months (P ≤0.001). Among hospitalized people living with HIV, 40.4% had persistent symptoms compared with 47.1% among participants without HIV (P = 0.108). The risk factors for PCC included older age, female sex, non-Black race, presence of a comorbidity, greater number of acute COVID-19 symptoms, hospitalization/COVID-19 severity, and wave period (lower risk of persistent symptoms for the Omicron compared with the Beta wave). There were no associations between self-reported vaccination status with persistent symptoms.

CONCLUSION:

The study revealed a high prevalence of persistent symptoms among South African participants at 6 months but decreased risk for PCC among participants infected during the Omicron BA.1 wave. These findings have serious implications for countries with resource-constrained health care systems.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV Infections / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid / Vaccines / Variants Limits: Adult / Female / Humans Country/Region as subject: Africa Language: English Journal: Int J Infect Dis Journal subject: Communicable Diseases Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV Infections / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid / Vaccines / Variants Limits: Adult / Female / Humans Country/Region as subject: Africa Language: English Journal: Int J Infect Dis Journal subject: Communicable Diseases Year: 2023 Document Type: Article